SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab
Clinical trial NCT03161431 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03161431
- Sponsor
- Syntrix Biosystems, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-12
- Primary completion
- 2026-08-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.